Literature DB >> 19887963

Medulloblastoma incidence has not changed over time: a CBTRUS study.

Sonia Partap1, Emily K Curran, Jennifer M Propp, Gem M Le, Kristin L Sainani, Paul Graham Fisher.   

Abstract

Earlier studies have reported changes in the incidence of medulloblastoma (MB) but have conflicted, likely because of small sample size or misclassification of MB with primitive neuroectodermal tumor (PNET). The incidence of MB and PNET from 1985 to 2002 was determined from the Central Brain Tumor Registry of the United States, a large population-based cancer registry, using strict histologic and site codes. No statistically significant change in MB incidence was observed over the last 2 decades, but there was an increase in MB and PNET combined.

Entities:  

Mesh:

Year:  2009        PMID: 19887963     DOI: 10.1097/MPH.0b013e3181bbc502

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  12 in total

1.  Incidence of medulloblastoma in Canadian children.

Authors:  Donna L Johnston; Daniel Keene; Maria Kostova; Douglas Strother; Lucie Lafay-Cousin; Chris Fryer; Katrin Scheinemann; Anne-Sophie Carret; Adam Fleming; Vanessa Percy; Samina Afzal; Beverly Wilson; Lynette Bowes; Shayna Zelcer; Chris Mpofu; Mariana Silva; Valerie Larouche; Josee Brossard; Eric Bouffet
Journal:  J Neurooncol       Date:  2014-08-17       Impact factor: 4.130

Review 2.  Proton therapy for the treatment of children with CNS malignancies.

Authors:  Radhika Sreeraman; Daniel J Indelicato
Journal:  CNS Oncol       Date:  2014-03

3.  Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013.

Authors:  Vishesh Khanna; Rebecca L Achey; Quinn T Ostrom; Hunter Block-Beach; Carol Kruchko; Jill S Barnholtz-Sloan; Peter M de Blank
Journal:  J Neurooncol       Date:  2017-08-21       Impact factor: 4.130

4.  Secreted meningeal chemokines, but not VEGFA, modulate the migratory properties of medulloblastoma cells.

Authors:  Monika A Davare; Sangeet Lal; Jennifer L Peckham; Suresh I Prajapati; Sakir H Gultekin; Brian P Rubin; Charles Keller
Journal:  Biochem Biophys Res Commun       Date:  2014-06-10       Impact factor: 3.575

5.  An oncolytic measles virus-sensitive Group 3 medulloblastoma model in immune-competent mice.

Authors:  Sangeet Lal; Diego Carrera; Joanna J Phillips; William A Weiss; Corey Raffel
Journal:  Neuro Oncol       Date:  2018-11-12       Impact factor: 12.300

6.  Interaction of hypoxia-inducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate.

Authors:  Francesca Pistollato; Elena Rampazzo; Luca Persano; Sara Abbadi; Chiara Frasson; Luca Denaro; Domenico D'Avella; David M Panchision; Alessandro Della Puppa; Renato Scienza; Giuseppe Basso
Journal:  Stem Cells       Date:  2010-11       Impact factor: 6.277

7.  Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastoma.

Authors:  Tara M Brinkman; Wilburn E Reddick; Joshua Luxton; John O Glass; Noah D Sabin; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Kevin R Krull
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

8.  Trends in childhood brain tumor incidence, 1973-2009.

Authors:  Roberta McKean-Cowdin; Pedram Razavi; Jessica Barrington-Trimis; Rachel Tobias Baldwin; Shahab Asgharzadeh; Myles Cockburn; Tarik Tihan; Susan Preston-Martin
Journal:  J Neurooncol       Date:  2013-08-08       Impact factor: 4.130

Review 9.  The clinical implications of medulloblastoma subgroups.

Authors:  Paul A Northcott; Andrey Korshunov; Stefan M Pfister; Michael D Taylor
Journal:  Nat Rev Neurol       Date:  2012-05-08       Impact factor: 42.937

10.  MRI surrogates for molecular subgroups of medulloblastoma.

Authors:  S Perreault; V Ramaswamy; A S Achrol; K Chao; T T Liu; D Shih; M Remke; S Schubert; E Bouffet; P G Fisher; S Partap; H Vogel; M D Taylor; Y J Cho; K W Yeom
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-15       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.